Limba
|
Imgatuzumab (Anti-ERBB1 / EGFR / HER1) is a glycoengineered monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 145.28 KD.
Price | 9.330,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Imgatuzumab (Anti-ERBB1 / EGFR / HER1) is a glycoengineered monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 145.28 KD. |